According to Kezar Life Sciences's latest financial reports the company's current EPS (TTM) is -$1.15. In 2022 the company made an earnings per share (EPS) of -$1.01 an increase over its 2021 EPS that were of -$1.03.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.15 | 13.86% |
2022 | -$1.01 | -1.94% |
2021 | -$1.03 | 6.19% |
2020 | -$0.97 | -47.28% |
2019 | -$1.84 | -56.03% |
2018 | -$4.19 | 539.79% |
2017 | -$0.65 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 89.57% | ๐บ๐ธ USA |